North America Pulmonary Function Testing Systems Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Pulmonary Function Testing Systems Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Pulmonary Function Testing Systems Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Pulmonary Function Testing Systems Market Regional Analysis

6.2 North America Pulmonary Function Testing Systems Market Revenue 2020-2028 (US$ Million)

6.3 North America Pulmonary Function Testing Systems Market Forecast Analysis

7. North America Pulmonary Function Testing Systems Market Analysis – by Type

7.1 Cart-Based PFT Systems and Stationery PFT Systems

7.1.1 Overview
7.1.2 Cart-Based PFT Systems and Stationery PFT Systems: North America Pulmonary Function Testing Systems Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. North America Pulmonary Function Testing Systems Market Analysis – by Test Type

8.1 Spirometry

8.1.1 Overview
8.1.2 Spirometry: North America Pulmonary Function Testing Systems Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Lung Volume

8.2.1 Overview
8.2.2 Lung Volume: North America Pulmonary Function Testing Systems Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Gas Exchange Testing

8.3.1 Overview
8.3.2 Gas Exchange Testing: North America Pulmonary Function Testing Systems Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 Maximum Voluntary Ventilation

8.4.1 Overview
8.4.2 Maximum Voluntary Ventilation: North America Pulmonary Function Testing Systems Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.5 Oxygen Titration Test

8.5.1 Overview
8.5.2 Oxygen Titration Test: North America Pulmonary Function Testing Systems Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. North America Pulmonary Function Testing Systems Market Analysis – by Component

9.1 Hardware

9.1.1 Overview
9.1.2 Hardware: North America Pulmonary Function Testing Systems Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Software

9.2.1 Overview
9.2.2 Software: North America Pulmonary Function Testing Systems Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Services

9.3.1 Overview
9.3.2 Services: North America Pulmonary Function Testing Systems Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. North America Pulmonary Function Testing Systems Market Analysis – by Application

10.1 Chronic Obstructive Pulmonary Disorder

10.1.1 Overview
10.1.2 Chronic Obstructive Pulmonary Disorder: North America Pulmonary Function Testing Systems Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.2 Asthma

10.2.1 Overview
10.2.2 Asthma: North America Pulmonary Function Testing Systems Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.3 Chronic Shortness of Breath

10.3.1 Overview
10.3.2 Chronic Shortness of Breath: North America Pulmonary Function Testing Systems Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.4 Restrictive Lung Disease

10.4.1 Overview
10.4.2 Restrictive Lung Disease: North America Pulmonary Function Testing Systems Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. North America Pulmonary Function Testing Systems Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Pulmonary Function Testing Systems Market Breakdown, by Key Country, 2023 and 2028 (%)
11.2.1.1 North America Pulmonary Function Testing Systems Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 US: North America Pulmonary Function Testing Systems Market Breakdown, by Type
11.2.1.1.2 US: North America Pulmonary Function Testing Systems Market Breakdown, by Test Type
11.2.1.1.3 US: North America Pulmonary Function Testing Systems Market Breakdown, by Component
11.2.1.1.4 US: North America Pulmonary Function Testing Systems Market Breakdown, by Application

11.2.1.2 Canada: North America Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Canada: North America Pulmonary Function Testing Systems Market Breakdown, by Type
11.2.1.2.2 Canada: North America Pulmonary Function Testing Systems Market Breakdown, by Test Type
11.2.1.2.3 Canada: North America Pulmonary Function Testing Systems Market Breakdown, by Component
11.2.1.2.4 Canada: North America Pulmonary Function Testing Systems Market Breakdown, by Application

11.2.1.3 Mexico : North America Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 Mexico : North America Pulmonary Function Testing Systems Market Breakdown, by Type
11.2.1.3.2 Mexico : North America Pulmonary Function Testing Systems Market Breakdown, by Test Type
11.2.1.3.3 Mexico : North America Pulmonary Function Testing Systems Market Breakdown, by Component
11.2.1.3.4 Mexico : North America Pulmonary Function Testing Systems Market Breakdown, by Application

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 COSMED Srl

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 KoKo PFT Ltd

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 MGC Diagnostics Corp

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Morgan Scientific Inc

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 ndd Medical Technologies Inc

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 PulmOne Advanced Medical Devices Ltd

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Schiller AG

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Vyaire Medical Inc

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Pulmonary Function Testing Systems Market